摘要:
The present invention provides a new class of solids supports for synthesis of modified oligomers of nucleic acids, and nucleic acid probes that have a format expediently synthesized on the new supports. Exemplary solid supports include at least one quencher bound through a linker to the solid support. Various exemplary embodiments include a moiety that stabilizes a duplex, triplex, or higher order aggregation (e.g. hybridization) of nucleic acids of which the oligomer of the invention is a component. Other components of the solid support include moieties that stabilize aggregations of nucleic acids, e.g. intercalators, minor groove binding moieties, bases modified with a stabilizing moiety (e.g. alkynyl moieties, and fluoroalkyl moieties), and conformational stabilizing moieties, such as those described in commonly owned U.S. Patent Application Publication No. 2007/0059752.
摘要:
Hydrophilic, chemiluminescent acridinium compounds of formula (II) containing zwitterions are disclosed. These acridinium compounds, when used as chemiluminescent labels in immunochemistry assays and the like, exhibit decreased non-specific binding to solid phases and provide increased assay sensitivity.
摘要:
The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, neurological disorders and immunological disorders.
摘要:
A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P 2 S 5 ·2 C 5 H 5 N as a thionating agent. A thionating agent which is crystalline P 2 S 5 ·2 C 5 H 5 N.
摘要:
A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P 2 S 5 ·2 C 5 H 5 N as a thionating agent. A thionating agent which is crystalline P 2 S 5 ·2 C 5 H 5 N.
摘要翻译:一种通过使用晶体P2S5将化合物中的基团> C = O(I)转化成基团> C = S(II)或在反应中得到硫代反应产物的组(II)的互变异构形式的方法 ·2 C5H5N作为硫化剂。 一种硫化剂,它是晶体P2S5·2C5H5N。
摘要:
The present invention relates to the use of a compound of formula (I):
in which R 1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R 2 and R 3 represent, independently of one another, a hydrogen atom, a (C 1 -C 6 )alkyl group, a (C 1 -C 6 )alkenyl group or an aryl group chosen from a phenyl, benzyl, imidazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, indazolyl, furyl and thienyl group, and their addition salts with pharmaceutically acceptable acids, in the preparation of a radiopharmaceutical composition intended for the diagnosis and/or treatment of melanoma.